Tecan launches digital tools to enhance lab productivity at SLAS 2024

Männedorf, Switzerland, January 30, 2024 – Tecan is proud to unveil two cutting-edge digital products – LabNavigator™ and Next-Gen Introspect™ –  at the SLAS2024 International Conference and Exhibition to improve the efficiency of laboratory operations. The new tools bring the transformative power of digitalization to laboratory operations, empowering researchers and lab technicians with the most advanced, user-friendly, integrated technologies.

The scale-up of laboratory research is often hindered by a lack of automation expertise and the complexity brought by disconnected workflows. As throughput increases, digitalization is crucial to overcoming these challenges by streamlining lab processes, as well as maximizing overall lab effectiveness and helping lab technicians to overcome skill barriers.

LabNavigator is a cloud-based, intuitive digital product that guides lab operators through end-to-end workflows using a single, straightforward interface. It builds an interconnected lab by seamlessly combining lab equipment – including Tecan liquid handling platforms and selected third-party devices – as part of an open digital ecosystem. LabNavigator creates easy-to-follow end-to-end workflows, enabling entry-level staff to effectively operate systems via a user-friendly interface that provides quick and easy onboarding. This not only multiplies the impact of experienced personnel, it increases the quality and reproducibility of lab processes. Overall, the ‘single pane of glass’ approach unifies heterogeneous automation systems to enable seamless scalability across multiple labs.

Tecan’s second digital product announcement is Next-Gen Introspect, which will be commercially released in Q2 2024. This state-of-the-art laboratory insights tool builds on Tecan’s well-established platform, Introspect. The next generation platform offers intuitive user experience, employing advanced data science to convert instrument and workflow data into actionable insights that will maximize the utilization, quality and performance of instrument fleets. Next-Gen Introspect unlocks service excellence by enabling remote diagnostics and service support, leading to higher instrument uptimes and fewer unplanned outages. The existing features focused on run success rates, consumables consumption and real-time monitoring, have been meticulously enhanced, helping lab managers to truly maximize their valuable resources. Both Next-Gen Introspect and LabNavigator are built on modern and secure back-end architectures, ensuring data and process security.

“The lab of the future is here,” said Dr Klaus Lun, Executive Vice President of Life Sciences Business Division at Tecan. “We have been empowering our customers to improve lab productivity through automation for over 40 years, and we are proud to champion the advantages of digitalization. With LabNavigator and Next-Gen Introspect, we can provide tangible results for our customers – reducing operator training needs, increasing run success rates, maximizing overall equipment and labor efficiencies, and providing data-driven actionable insights.”

These digital tools are among a host of innovative developments that Tecan is looking forward to presenting at SLAS2024. Join us on booth #1031 to discover innovation designed for liquid biopsy, proteomics sample prep, and 3D cell biology, as well as the transformative power of digitalization with LabNavigator and Next-Gen Introspect. Alternatively, visit www.tecan.com/SLAS2024 or join our exhibitor tutorial Lab of today – get the digital advantage now at SLAS2024. 

For further information

Tecan Group
Benjamin Peltier 
Senior Manager Media and Content
benjamin.peltier@tecan.com
Tel. +41 (0) 44 922 88 88

About Tecan

Tecan (www.tecan.com) improves people’s lives and health by empowering customers to scale healthcare innovation globally from life science to the clinic. Tecan is a pioneer and global leader in laboratory automation. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments, components and medical devices that are then distributed by partner companies. Founded in Switzerland in 1980, the company has around 3,500 employees, with manufacturing, research and development sites in Europe, North America and Asia, and maintains a sales and service network in over 70 countries. In 2022, Tecan generated sales of CHF 1,144 million (USD 1,192 million; EUR 1,144 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).